|
시장보고서
상품코드
2055346
비식별 보건의료 데이터 시장 : 데이터 유형별, 용도별, 최종사용자별, 지역별De-Identified Health Data Market, By Type of Data, By Application, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
비식별 보건의료 데이터 시장은 2026년 90억 달러로 추정되며, 2033년까지 169억 7,000만 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 9.5%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 90억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 9.50% | 2033년 시장 규모 예측 : | 169억 7,000만 달러 |
비식별 보건의료 데이터 시장의 성장은 신약 개발 및 정밀 의학을 위한 연구 개발 활동 증가에 힘입어 이루어지고 있습니다. 익명화란 의료 데이터 세트에서 성명, 생년월일, 사회보장번호 등의 식별 정보를 삭제함으로써 환자의 사생활과 기밀성을 보장하는 것을 말합니다. 이를 통해 연구자 및 생명과학 기업들은 윤리적 문제를 야기하지 않으면서도 새로운 치료법 개발이나 역학 연구를 위해 방대한 의료 데이터를 활용할 수 있게 됩니다. 전 세계적으로 의료 기록의 디지털화가 가속화됨에 따라, 2차 이용이 가능한 비식별화 데이터의 양은 계속 늘어날 것입니다.
시장 역학
가치 기반 의료에 대한 관심 증가, 치료의 개인화, 그리고 디지털 헬스 스타트업의 성장은 전 세계적으로 비식별 보건의료 데이터에 대한 수요를 촉진할 가능성이 있습니다. 그러나 데이터 표준화의 부재와 지적 재산권에 관한 불명확성은 시장의 잠재력을 저해할 우려가 있습니다. 고도의 분석 역량을 개발함으로써, 각 참여자는 통합된 데이터 자산에서 더 심층적인 인사이트를 얻을 수 있는 기회를 얻게 됩니다. 정부의 오픈 데이터 공유 노력 확대는 이러한 데이터 세트에 대한 접근성을 높일 가능성이 있습니다. 미국 정부는 공중보건 연구 분야의 투명성과 혁신을 촉진하기 위해 Data.gov 및 HealthData.gov와 같은 이니셔티브를 출범시켜, 광범위한 건강 관련 데이터 세트에 대한 공개 접근을 제공합니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 익명화 의료 데이터 시장의 주요 기업 프로파일을 작성하고 있습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 비식별화 의료 데이터 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 비식별화 의료 데이터 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 비식별 보건의료 데이터 시장 : 데이터 유형별, 2021년-2033년
제5장 비식별 보건의료 데이터 시장 : 용도별, 2021년-2033년
제6장 비식별 보건의료 데이터 시장 : 최종사용자별, 2021년-2033년
제7장 비식별 보건의료 데이터 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
LSH 26.06.23De-Identified Health Data Market is estimated to be valued at USD 9 Bn in 2026 and is expected to reach USD 16.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 9 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.50% | 2033 Value Projection: | USD 16.97 Bn |
De identified health data market growth is driven by increasing research and development activities for drug discovery and precision medicine. De identification ensures patient privacy and confidentiality by removing identifiers such as name, date of birth, social security number, and others from health data sets. This allows researchers and life science companies to utilize large pools of health data for developing novel therapies and epidemiological studies without compromising on ethics. As digitization of health records accelerates across the world, there will be increase in amount of de identified data available for secondary usage.
Market Dynamics
Rising focus on value based care, personalization of treatment, and growth of digital health startups can boost demand for de identified health data globally. However, lack of data standardization and ambiguity over intellectual property rights can hamper the market potential. Development of advanced analytics capabilities offers an opportunity for players to unlock deeper insights from pooled data assets. Growing open data sharing initiatives by governments can widen the access to these data sets. The U.S. government has launched initiatives like Data.gov and HealthData.gov that offers open access to a wide range of health related datasets to encourage transparency and innovation in public health research.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global de identified health data market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include IQVIA, Oracle (Cerner Corporation), Merative (Truven Health Analytics), Optum, Inc., BioTelemetry, Inc., Flatiron Health, Veradigm LLC, Medidata Solutions, Evidation Health, Inc., Komodo Health, Inc., Sundown Solutions, LLC, Clarify Health Solutions, Akrivia Health, Satori Cyber Ltd., Tempus, nference, Ciox Health, HealthVerity, Zebra Medical Vision, and Huma Therapeutics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up gradation, market expansion, and marketing tactics.
- Global de identified health data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global de identified health data market.
Market Segmentation
- Type of Data Insights (Revenue, USD Bn, 2021 - 2033)
- Clinical Data
- Genomic Data
- Patient Demographics
- Prescription Data
- Claims Data
- Behavioral Data
- Wearable and Sensor Data
- Survey and Patient-Reported Data
- Imaging Data
- Laboratory Data
- Social Determinants of Health (SDOH) Data
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Clinical Research and Trials
- Public Health
- Precision Medicine
- Health Economics and Outcomes Research (HEOR)
- Population Health Management
- Drug Discovery and Development
- Healthcare Quality Improvement
- Insurance Underwriting and Risk Assessment
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical Companies
- Biotechnology Firms
- Healthcare Providers
- Insurance Companies/Healthcare Payers
- Research Institutions
- Government Agencies
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- IQVIA
- Oracle (Cerner Corporation)
- Merative (Truven Health Analytics)
- Optum, Inc.
- BioTelemetry, Inc.
- Flatiron Health
- Veradigm LLC
- Medidata Solutions
- Evidation Health, Inc.
- Komodo Health, Inc.
- Sundown Solutions, LLC
- Clarify Health Solutions
- Akrivia Health
- Satori Cyber Ltd.
- Tempus
- nference
- Ciox Health
- HealthVerity
- Zebra Medical Vision
- Huma Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- De-identified Health Data Market, By Type of Data
- De-identified Health Data Market, By Application
- De-identified Health Data Market, By End User
- De-identified Health Data Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. De-identified Health Data Market, By Type of Data, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clinical Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Genomic Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Patient Demographics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Prescription Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Claims Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Behavioral Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Wearable and Sensor Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Survey and Patient-Reported Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Imaging Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Laboratory Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Social Determinants of Health (SDOH) Data
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. De-identified Health Data Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Clinical Research and Trials
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Public Health
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Precision Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Health Economics and Outcomes Research (HEOR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Population Health Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Healthcare Quality Improvement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Insurance Underwriting and Risk Assessment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. De-identified Health Data Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Biotechnology Firms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Healthcare Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Insurance Companies/Healthcare Payers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Government Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. De-identified Health Data Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type of Data, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive landscape
- IQVIA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oracle (Cerner Corporation)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merative (Truven Health Analytics)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Optum, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioTelemetry, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Flatiron Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Veradigm LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medidata Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evidation Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Komodo Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sundown Solutions, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Clarify Health Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Akrivia Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Satori Cyber Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tempus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- nference
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ciox Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HealthVerity
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zebra Medical Vision
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Huma Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
